Exagen XGN
Exagen reports Q3 2026 financial results
Exagen (XGN) filed an 8-K with the SEC on Nov 10, 2026, 7:33 am ET. Source: the filing on SEC EDGAR.
Item 2.02 Reports results
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001274737-26-000063
- Revenue grew 7% to $18.4 million
- Net loss reduced by 12% to $6.3 million
- Adjusted EBITDA loss improved by 30%
Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.
